| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.67 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.31 | 0.08 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.27 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.0009 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.22 | 0.3 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.08 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.19 | 0.4 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |